Veterinary Medicines

Pneumovac Plus Suspension for Injection for Cattle

Authorised
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
  • Bovine viral diarrhoea virus, strain BIO-25, Inactivated
Download as PDF

Product identification

Medicine name:
Pneumovac Plus suspension for injection for cattle
Pneumovac Plus Suspension for Injection for Cattle
Active substance:
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
  • Bovine viral diarrhoea virus, strain BIO-25, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain BIO-24, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine parainfluenza virus 3, strain BIO-23, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A1, strain DSM 5283, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine viral diarrhoea virus, strain BIO-25, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • The vaccine is filled in glass vials:Hydrolytic type I 10ml vials containing 10 ml (5 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows: 10 x 10ml in a transparent plastic box with cover. Carton for mass packaging 10 x 10 mlEach package contains an approved Package Leaflet
  • The vaccine is filled in glass vials:100ml vials containing 100 ml (50 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows:1 x 100ml in cardboard boxes. Each package contains an approved Package Leaflet.
  • The vaccine is filled in glass vials:Hydrolytic type I 50ml vials containing 50 ml (25 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows:1 x 50ml in cardboard boxes. Each package contains an approved Package Leaflet.
  • The vaccine is filled in glass vials:Hydrolytic type I 10ml vials containing 10 ml (5 doses). All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals. The product is delivered as follows:1 x 10ml in cardboard boxes. Each package contains an approved Package Leaflet.
  • In plastic vials:15ml vials containing 10 ml (5 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows:1 x 10ml in cardboard boxesEach package contains an approved Package Leaflet
  • In plastic vials:60ml vials containing 50ml (25 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows:1 x 50ml in cardboard boxesEach package contains an approved Package Leaflet
  • In plastic vials:120ml vials containing 100ml (50 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows:1 x 100ml in cardboard boxesEach package contains an approved Package Leaflet
  • In plastic vials:15ml vials containing 10 ml (5 doses)All containers are closed with chlorobutyl rubber stoppers and secured with aluminium seals.The product is delivered as follows: 10 x 10ml in a transparent plastic box with cover. Carton for mass packaging 10 x 10 mlEach package contains an approved Package Leaflet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Animal Health Distributors Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 51609/4001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0639/001
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download